Vektor Mapping System for Atrial Fibrillation

Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study

Recruiting N/A Interventional Study
Atrial Fibrillation (AF)
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
22 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
423 (estimated)
Sponsor
Vektor Medical · Industry
Who this trial is looking for

This trial is looking for adults with atrial fibrillation (AF) who need a medical procedure. Participants will have a chance to receive a new mapping system along with standard treatment.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have been diagnosed with persistent or recurrent atrial fibrillation.
  • I have a recent ECG recording of my atrial fibrillation.
  • I am 22 years of age or older.
  • I need to undergo an ablation procedure.
  • I can follow the study requirements.

You may not be able to join if

  • I have arrhythmias other than persistent or recurrent atrial fibrillation.
  • I cannot provide a good quality ECG prior to the procedure.
  • I am enrolled in another clinical trial with a test drug or device.
  • I have a medical condition that may pose a risk if I participate.
  • I am pregnant.
  • I have had prior pulmonary vein isolation and all veins are isolated.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
The goal of this clinical trial is to compare the use of the Vektor Computational ECG Mapping System (vMap®) with pulmonary vein isolation (PVI), to using PVI alone, to treat Atrial Fibrillation (AF) in adults. Participants will have a 50/50 or 1 out of 2 chance of being placed in the treatment or control arm. The control arm of the study involves PVI alone for ablation procedure(s). The treatmen…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Subjects diagnosed with persistent (not longstanding) AF or recurrent AF, as defined for this study. 2. Subject has a recent 12-lead electrogram data of AF (including baseline, pacing and clinical arrhythmia) recorded on the electrogram recording system (e.g., Bard, Boston-Sc…
Contacts

No contact information available.